Intravesical instillation of BCG or anticancer agents after transurethral resection is currently considered a standard of therapy. However, this approach is basically empirical; none of the anticancer agents used in this setting was specifically formulated for intravesical therapy. Moreover, concern is raised by the kinetic features of water soluble drugs, because of poor transport across the mucosal barrier, or of liphophylic compounds, for the increased risks of systemic toxicity. A need exists to improve the pre-clinical and clinical approaches used at present to test anticancer agents undergoing specific development for intravesical use. We used in vitro rabbit whole bladders as a new pre-clinical model to investigate the kinetics of lo...
INTRODUCTION: Gemcitabine is a deoxycytidine analogue, used intravenously in the treatment of severa...
As well as being a passive support, the extracellular matrix also regulates key biological processes...
Intravesical chemo/immunotherapy is a constituent of combination treatment for bladder cancer and wi...
Intravesical instillation of BCG or anticancer agents after transurethral resection is currently con...
Intravesical instillation of BCG or anticancer agents after transurethral resection is currently con...
Objectives: The intravesical route permits site-specific delivery of drugs with a reduced side-effec...
Objectives: The intravesical route permits site-specific delivery of drugs with a reduced side-effec...
Background: Tumor recurrence is the most expected clinical event after the resection of non-muscle i...
BACKGROUND: Tumor recurrence is the most expected clinical event after the resection of non-muscle ...
Les pathologies vésicales sont nombreuses et nécessitent la plupart du temps un traitement médicamen...
Trials have demonstrated a reduction in bladder cancer recurrence rates of approximately 45% followi...
Leaf Huang Ph.D.INTRAVESICAL THERAPY OF INTERSTITIAL CYSTITISPradeep Tyagi, Ph.D.University of Pitts...
Purpose: Paclitaxel, on systemic administration, is widely known to be effective in the treatment of...
Bladder diseases are numerous and mostly require medication. Drugs can be administered by intravesic...
Transurothelial drug delivery continues to be an attractive treatment option for a range of urologic...
INTRODUCTION: Gemcitabine is a deoxycytidine analogue, used intravenously in the treatment of severa...
As well as being a passive support, the extracellular matrix also regulates key biological processes...
Intravesical chemo/immunotherapy is a constituent of combination treatment for bladder cancer and wi...
Intravesical instillation of BCG or anticancer agents after transurethral resection is currently con...
Intravesical instillation of BCG or anticancer agents after transurethral resection is currently con...
Objectives: The intravesical route permits site-specific delivery of drugs with a reduced side-effec...
Objectives: The intravesical route permits site-specific delivery of drugs with a reduced side-effec...
Background: Tumor recurrence is the most expected clinical event after the resection of non-muscle i...
BACKGROUND: Tumor recurrence is the most expected clinical event after the resection of non-muscle ...
Les pathologies vésicales sont nombreuses et nécessitent la plupart du temps un traitement médicamen...
Trials have demonstrated a reduction in bladder cancer recurrence rates of approximately 45% followi...
Leaf Huang Ph.D.INTRAVESICAL THERAPY OF INTERSTITIAL CYSTITISPradeep Tyagi, Ph.D.University of Pitts...
Purpose: Paclitaxel, on systemic administration, is widely known to be effective in the treatment of...
Bladder diseases are numerous and mostly require medication. Drugs can be administered by intravesic...
Transurothelial drug delivery continues to be an attractive treatment option for a range of urologic...
INTRODUCTION: Gemcitabine is a deoxycytidine analogue, used intravenously in the treatment of severa...
As well as being a passive support, the extracellular matrix also regulates key biological processes...
Intravesical chemo/immunotherapy is a constituent of combination treatment for bladder cancer and wi...